AbbVie Inc. ↗

Part of AbbVie.

2012 📍 United States NYSE ABBV

Search companies

Key Metrics of AbbVie Inc.

Revenue$54.3B▼ 6.4% YoYFY 2023

Operating income$12.8B▼ 29.6% YoY

Net profit$4.9B▼ 58.9% YoY

Shareholders' equity$10.4B

Market cap$506BABBV · $286.39

Open jobs8

About AbbVie Inc.

Part of AbbVie.

Company details

Website: abbvie.com.au
Founded: 2012
Listed: NYSE: ABBV (since 2012)

Company summary

Legal nameAbbVie Inc.

TickerABBV

ExchangeNYSE

CountryUnited States

SEC CIK0001551152

Listed since2012

IndustryBiotechnology: Pharmaceutical Preparations

SectorOther Industries · Discovered Companies

Websitehttps://www.abbvie.com.au

US market & SEC filings

ABBV · NYSE · SEC CIK 0001551152

Last price · 29 Oct 2026 $286.39 −0.12%

Market cap$506B

P/E105.3On FY 2023 diluted EPS

Volume3,269,371

SectorHealth CareBiotechnology: Pharmaceutical Preparations

Country · IPOUnited StatesListed 2012

ABBV share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Vendor checks & payment capacity

Registered office and contact

Registered office—

GSTIN—

Email—

Websitehttps://www.abbvie.com.au

Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Part of AbbVie

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.